Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
Hosono Y, Sie B, Pinal-Fernandez I, Pak K, Mecoli CA, Casal-Dominguez M, Warner BM, Kaplan MJ, Albayda J, Danoff S, Lloyd TE, Paik JJ, Tiniakou E, Aggarwal R, Oddis CV, Moghadam-Kia S, Carmona-Rivera C, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Christopher-Stine L, Larman HB, Mammen AL.
Hosono Y, et al. Among authors: mecoli ca.
Ann Rheum Dis. 2023 Feb;82(2):246-252. doi: 10.1136/ard-2022-222441. Epub 2022 Aug 25.
Ann Rheum Dis. 2023.
PMID: 36008132
Free PMC article.